# Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic Syndrome

> **NCT03899103** · PHASE3 · COMPLETED · sponsor: **Nilratan Sircar Medical College** · enrollment: 100 (actual)

## Conditions studied

- Steroid-Dependent Nephrotic Syndrome

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT03899103
- **Lead sponsor:** Nilratan Sircar Medical College
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-15
- **Primary completion:** 2023-09-05
- **Final completion:** 2023-12-24
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03899103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03899103, "Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03899103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*